Gerber Kawasaki Wealth & Investment Management Pacific Biosciences Of California, Inc. Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.16 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$19.26 - $30.08 $19 - $30	-1 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $24 - $35	1 New	1 $1,000

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

33.4M
Shares

$65.8 Million
0.54% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$46.5 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$46.1 Million
6.35% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

20.3M
Shares

$40 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

17.6M
Shares

$34.8 Million
0.0% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account